Autre

TITRE Cancers avec altérations moléculaires rares au Canada (CARMA) – Étude ouverte observationnelle en situation réelle (BROS)
PROTOCOLE ID CARMA-BROS
CLINICAL TRIAL.gov ID NCT04151342
TYPE(S) DE CANCER Autre
PHASE Autres
TYPE D'ÉTUDE Autre
INSTITUTION CHUM
1051 rue Sanguinet
(514) 890-8000
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Normand Blais
COORDONATEUR(RICE) Wiam Belkaid
wiam.belkaid.chum@ssss.gouv.qc.ca
514-890-8000
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Patients ≥ 18 years at cancer diagnosis
  • Diagnosed with malignant tumour(s) with molecular testing completed that identified rare molecular alterations
  • Accessible/available molecular testing reports/documentation to confirm type(s) of molecular alteration(s) (resulting from the conduct of polymerase chain reaction [PCR] based next generation sequencing [NGS], immunohistochemistry [IHC], fluorescence in situ hybridization [FISH])
  • Canadian resident received follow-up for cancer care in Canada or is currently receiving/planning follow-up for cancer care to occur in Canada at time of enrollment
CRITÈRES D'EXCLUSION (EN)
  • Previous refusal of the deceased patient, when living, to enroll in this study or patient approached for this study is unable to provide informed consent